Simickova M - Search Results

1

Predicting response of ovarian cancer to paclitaxel treatment based on trend analysis of serum CA125.

Nekulova M, Pecen L, Kalabova R, Simickova M, Topolcan O, Pikner R, Vondracek V, Valik D. Nekulova M, et al. Among authors: simickova m. Clin Chem. 2002 Aug;48(8):1364-7. Clin Chem. 2002. PMID: 12142397 No abstract available.

2

Early diagnosis of breast cancer dissemination by tumor markers follow-up and method of prediction.

Nekulová M, Simícková M, Pecen L, Eben K, Vermousek I, Stratil P, Cernoch M, Lang B. Nekulová M, et al. Among authors: simickova m. Neoplasma. 1994;41(2):113-8. Neoplasma. 1994. PMID: 8208314

3

Quantitative determination of telomerase activity in breast cancer and benign breast diseases.

Simícková M, Nekulová M, Pecen L, Cernoch M, Vagundová M, Pacovský Z. Simícková M, et al. Neoplasma. 2001;48(4):267-73. Neoplasma. 2001. PMID: 11712677

4

Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel.

Oikonomopoulou K, Li L, Zheng Y, Simon I, Wolfert RL, Valik D, Nekulova M, Simickova M, Frgala T, Diamandis EP. Oikonomopoulou K, et al. Among authors: simickova m. Br J Cancer. 2008 Oct 7;99(7):1103-13. doi: 10.1038/sj.bjc.6604630. Epub 2008 Sep 2. Br J Cancer. 2008. PMID: 18766180 Free PMC article.

5

Release of cytokeratin-18 and -19 fragments (TPS and CYFRA 21-1) into the extracellular space during apoptosis.

Sheard MA, Vojtesek B, Simickova M, Valik D. Sheard MA, et al. Among authors: simickova m. J Cell Biochem. 2002;85(4):670-7. doi: 10.1002/jcb.10173. J Cell Biochem. 2002. PMID: 11968007

6

Significance of pre-treatment immunological parameters in colorectal cancer patients with unresectable metastases to the liver.

Zaloudik J, Lauerova L, Janakova L, Talac R, Simickova M, Nekulova M, Mikulikova I, Kovarik J, Sheard M. Zaloudik J, et al. Among authors: simickova m. Hepatogastroenterology. 1999 Jan-Feb;46(25):220-7. Hepatogastroenterology. 1999. PMID: 10228796

7

Phylloid breast tumors and three steroid hormone receptors.

Lang BA, Vermousek I, Simicková M, Cernoch M, Nekulová M, Paćovský Z, Rejthar A. Lang BA, et al. Among authors: simickova m. Neoplasma. 1997;44(1):53-7. Neoplasma. 1997. PMID: 9201281

8

Relation of prenephrectomy CD profiles and serum cytokines to the disease outcome and response to IFN-alpha/IL-2 therapy in renal cell carcinoma patients.

Lauerová L, Dusek L, Spurny V, Simicková M, Rovny A, Rejthar A, Kocák I, Kovarík J. Lauerová L, et al. Among authors: simickova m. Oncol Rep. 2001 May-Jun;8(3):685-92. Oncol Rep. 2001. PMID: 11295103

9

Renal cell carcinoma-associated immune impairment that may interfere with the response to cytokine therapy.

Lauerová L, Dusek L, Simícková M, Rovný F, Spurný V, Rovný A, Slampa P, Zaloudík J, Rejthar A, Wotke J, Kovarík J. Lauerová L, et al. Among authors: simickova m. Neoplasma. 1999;46(3):141-9. Neoplasma. 1999. PMID: 10613588

10

Homocysteine in breast cyst fluid.

Tallova J, Tomandl J, Bicikova M, Simickova M. Tallova J, et al. Among authors: simickova m. Eur J Clin Invest. 2001 Jul;31(7):623-7. doi: 10.1046/j.1365-2362.2001.00857.x. Eur J Clin Invest. 2001. PMID: 11454018

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters